The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Open accessAbstract
This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier. Dosages, indications, and methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the professional literature or other clinical sources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
GRADE guidelines 6. Rating the quality of evidence—imprecision
Guyatt, G. H., Oxman, A. D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., Devereaux, P. J., Montori, V. M., Freyschuss, B., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.012 · Cited by 2,693
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Self-citationThe Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Weening, J. J., D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T., Ferrario, F., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108969.21691.5d · Cited by 2,008
Rock, G. A., Shumak, K. H., Buskard, N. A., Blanchette, V. S., Kelton, J. G., Nair, R. C., & Spasoff, R. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250604 · Cited by 1,920
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Self-citationCervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Mejía, J. C., Aydintug, A. O., Chwalinska-Sadowska, H., de Ramón, E., et al. (2003) · Medicine · doi:10.1097/01.md.0000091181.93122.55 · Cited by 1,377
Syndromes of Thrombotic Microangiopathy
George, J. N., & Nester, C. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312353 · Cited by 1,279
Austin, H. A., Klippel, J. H., Balow, J. E., Le Riche, N. G. H., Steinberg, A. D., Plotz, P. H., & Decker, J. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141004 · Cited by 1,185
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Petri, M., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M., Merrill, J. T., Belmont, H. M., Askanase, A. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051135 · Cited by 1,166
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C., Kim, M. Y., Buyon, J., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,128
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sa[Combining Acute Accent]nchez-Guerrero, J., Solomons, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101028 · Cited by 1,118
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., Garrido, E. D. R., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10461 · Cited by 1,077
Bajema, I. M., Wilhelmus, S., Alpers, C. E., Bruijn, J. A., Colvin, R. B., Cook, H. T., D’Agati, V. D., Ferrario, F., Haas, M., Jennette, J. C., et al. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.023 · Cited by 1,058
STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
Remmers, E. F., Plenge, R. M., Lee, A. T., Graham, R. R., Hom, G., Behrens, T. W., de Bakker, P. I. W., Le, J. M., Lee, H.-S., Batliwalla, F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073003 · Cited by 1,041
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Furie, R., Rovin, B. H., Houssiau, F., Malvar, A., Teng, Y. K. O., Contreras, G., Amoura, Z., Yu, X., Mok, C.-C., Santiago, M. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001180 · Cited by 1,032
Self-citationCaplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
Scully, M., Cataland, S. R., Peyvandi, F., Coppo, P., Knöbl, P., Kremer Hovinga, J. A., Metjian, A., de la Rubia, J., Pavenski, K., Callewaert, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1806311 · Cited by 1,025
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis
Chan, T. M., Li, F. K., Tang, C. S. O., Wong, R. W. S., Fang, G. X., Ji, Y. L., Lau, C. S., Wong, A. K. M., Tong, M. K. L., Chan, K. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431604 · Cited by 954
Self-citationAndreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., Doria, A., Fischer-Betz, R., Forger, F., Moraes-Fontes, M. F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209770 · Cited by 945
Scully, M., Hunt, B. J., Benjamin, S., Liesner, R., Rose, P., Peyvandi, F., Cheung, B., Machin, S. J., & on behalf of British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09167.x · Cited by 863
Boumpas, D. T., Austin, H. A., Balow, J. E., Vaughan, E. M., Yarboro, C. H., Klippel, J. H., & Steinberg, A. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)92292-n · Cited by 823
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Pengo, V., Denas, G., Zoppellaro, G., Jose, S. P., Hoxha, A., Ruffatti, A., Andreoli, L., Tincani, A., Cenci, C., Prisco, D., et al. (2018) · Blood · doi:10.1182/blood-2018-04-848333 · Cited by 822
Sequential Therapies for Proliferative Lupus Nephritis
Contreras, G., Pardo, V., Leclercq, B., Lenz, O., Tozman, E., O'Nan, P., & Roth, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031855 · Cited by 818
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.005 · Cited by 701
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Peyvandi, F., Scully, M., Kremer Hovinga, J. A., Cataland, S., Knöbl, P., Wu, H., Artoni, A., Westwood, J.-P., Mansouri Taleghani, M., Jilma, B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505533 · Cited by 666
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Dooley, M. A., Jayne, D., Ginzler, E. M., Isenberg, D., Olsen, N. J., Wofsy, D., Eitner, F., Appel, G. B., Contreras, G., Lisk, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014460 · Cited by 642
Rovin, B. H., Teng, Y. K. O., Ginzler, E. M., Arriens, C., Caster, D. J., Romero-Diaz, J., Gibson, K., Kaplan, J., Lisk, L., Navarra, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00578-x · Cited by 635
Self-citationA national study of the complications of lupus in pregnancy
Clowse, M. E. B., Jamison, M., Myers, E., & James, A. H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.03.012 · Cited by 609
Gourley, M. F., Austin III, H. A., Scott, D., Yarboro, C. H., Vaughan, E. M., Muir, J., Boumpas, D. T., Klippel, J. H., Balow, J. E., & Steinberg, A. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00003 · Cited by 607
International, F. H., Loirat, C., Fakhouri, F., Ariceta, G., Besbas, N., Bitzan, M., Bjerre, A., Coppo, R., Emma, F., Johnson, S., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-015-3076-8 · Cited by 596
Population‐based assessment of adverse events associated with long‐term glucocorticoid use
Curtis, J. R., Westfall, A. O., Allison, J., Bijlsma, J. W., Freeman, A., George, V., Kovac, S. H., Spettell, C. M., & Saag, K. G. (2006) · Arthritis Care & Research · doi:10.1002/art.21984 · Cited by 595
AGREE II: Advancing guideline development, reporting and evaluation in health care
Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.001 · Cited by 563
Bendapudi, P. K., Hurwitz, S., Fry, A., Marques, M. B., Waldo, S. W., Li, A., Sun, L., Upadhyay, V., Hamdan, A., Brunner, A. M., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30026-1 · Cited by 561
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Cauli, A., Direskeneli, H., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102533 · Cited by 542
Buckley, L., Guyatt, G., Fink, H. A., Cannon, M., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40137 · Cited by 527
Houssiau, F. A., D'Cruz, D., Sangle, S., Remy, P., Vasconcelos, C., Petrovic, R., Fiehn, C., de Ramon Garrido, E., Gilboe, I.-M., Tektonidou, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131995 · Cited by 499
Illei, G. G., Austin, H. A., Crane, M., Collins, L., Gourley, M. F., Yarboro, C. H., Vaughan, E. M., Kuroiwa, T., Danning, C. L., Steinberg, A. D., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00009 · Cited by 492
Feldman, C. H., Hiraki, L. T., Liu, J., Fischer, M. A., Solomon, D. H., Alarcón, G. S., Winkelmayer, W. C., & Costenbader, K. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37795 · Cited by 487
Chan, T.-M., Tse, K.-C., Tang, C. S.-O., Mok, M.-Y., & Li, F.-K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080686 · Cited by 479
Self-citationA Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis
Lewis, E. J., Hunsicker, L. G., Lan, S.-P., Rohde, R. D., & Lachin, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262101 · Cited by 473
Condon, M. B., Ashby, D., Pepper, R. J., Cook, H. T., Levy, J. B., Griffith, M., Cairns, T. D., & Lightstone, L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202844 · Cited by 454
Pons-Estel, B. A., Catoggio, L. J., Cardiel, M. H., Soriano, E. R., Gentiletti, S., Villa, A. R., Abadi, I., Caeiro, F., Alvarellos, A., & Alarcón-Segovia, D. (2004) · Medicine · doi:10.1097/01.md.0000104742.42401.e2 · Cited by 447
Licht, C., Greenbaum, L. A., Muus, P., Babu, S., Bedrosian, C. L., Cohen, D. J., Delmas, Y., Douglas, K., Furman, R. R., Gaber, O. A., et al. (2015) · Kidney International · doi:10.1038/ki.2014.423 · Cited by 420
Stohl, W., Schwarting, A., Okada, M., Scheinberg, M., Doria, A., Hammer, A. E., Kleoudis, C., Groark, J., Bass, D., Fox, N. L., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40049 · Cited by 420
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Ruiz-Irastorza, G., Egurbide, M.-V., Pijoan, J.-I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., Erdozain, J.-G., & Aguirre, C. (2006) · Lupus · doi:10.1177/0961203306071872 · Cited by 411
Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized Trial
Liu, Z., Zhang, H., Liu, Z., Xing, C., Fu, P., Ni, Z., Chen, J., Lin, H., Liu, F., He, Y., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1030 · Cited by 396
Self-citationHoussiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20666 · Cited by 391
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias
Allford, S. L., Hunt, B. J., Rose, P., Machin, S. J., & on behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04049.x · Cited by 383
Fessler, B. J., Alarcón, G. S., McGwin, G., Roseman, J., Bastian, H. M., Friedman, A. W., Baethge, B. A., Vilá, L., Reveille, J. D., & for the LUMINA Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21039 · Cited by 377
Factors predictive of outcome in severe lupus nephritis
Korbet, S. M., Lewis, E. J., Schwartz, M. M., Reichlin, M., Evans, J., & Rohde, R. D. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70262-9 · Cited by 374
Thrombotic Microangiopathy and the Kidney
Brocklebank, V., Wood, K. M., & Kavanagh, D. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00620117 · Cited by 373
Angeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., & Giustina, A. (2006) · Bone · doi:10.1016/j.bone.2006.02.005 · Cited by 365
Bastian, H. M., Roseman, J. M., Mcgwin, G., Alarcón, G. S., Friedman, A. W., Fessler, B. J., Baethge, B. A., Reveille, J. D., & Lumina Study Group (2002) · Lupus · doi:10.1191/0961203302lu158oa · Cited by 360
Tektonidou, M. G., Laskari, K., Panagiotakos, D. B., & Moutsopoulos, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24232 · Cited by 356
Yurkovich, M., Vostretsova, K., Chen, W., & Aviña‐Zubieta, J. A. (2014) · Arthritis Care & Research · doi:10.1002/acr.22173 · Cited by 356
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
Isenberg, D., Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Jayne, D., Sánchez-Guerrero, J., Wofsy, D., Yu, X., & Solomons, N. (2010) · Rheumatology · doi:10.1093/rheumatology/kep346 · Cited by 356
Mysler, E. F., Spindler, A. J., Guzman, R., Bijl, M., Jayne, D., Furie, R. A., Houssiau, F. A., Drappa, J., Close, D., Maciuca, R., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38037 · Cited by 353
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
The European Paediatric Study Group for HUS, Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C., Loirat, C., Pecoraro, C., Taylor, C. M., et al. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-0964-1 · Cited by 352
Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study
Furie, R., Nicholls, K., Cheng, T., Houssiau, F., Burgos‐Vargas, R., Chen, S., Hillson, J. L., Meadows‐Shropshire, S., Kinaszczuk, M., & Merrill, J. T. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38260 · Cited by 341
Bucciarelli, S., Espinosa, G., Cervera, R., Erkan, D., Gómez‐Puerta, J. A., Ramos‐Casals, M., Font, J., & Asherson, R. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22018 · Cited by 334
COMMITTEE ON STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES
Graham, R. P., Mancher, M., Wolman, D. M., Greenfield, S., & Steinberg, E. P. (2011) · Cited by 334
Dall'Era, M., Cisternas, M. G., Smilek, D. E., Straub, L., Houssiau, F. A., Cervera, R., Rovin, B. H., & Mackay, M. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39026 · Cited by 329
Self-citationSurvival analysis and causes of mortality in patients with lupus nephritis
Yap, D. Y. H., Tang, C. S. O., Ma, M. K. M., Lam, M. F., & Chan, T. M. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs073 · Cited by 319
Self-citationRadis, C. D., Kahl, L. E., Baker, G. L., Wasko, M. C. M., Cash, J. M., Gallatin, A., Stolzer, B. L., Agarwal, A. K., Medsger, T. A., & Kwoh, C. K. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380815 · Cited by 314
Value of a Complete or Partial Remission in Severe Lupus Nephritis
Chen, Y. E., Korbet, S. M., Katz, R. S., Schwartz, M. M., & Lewis, E. J. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03280807 · Cited by 312
Rovin, B. H., Solomons, N., Pendergraft, W. F., Dooley, M. A., Tumlin, J., Romero-Diaz, J., Lysenko, L., Navarra, S. V., Huizinga, R. B., Adzerikho, I., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.08.025 · Cited by 309
Self-citationPons‐Estel, G. J., Alarcón, G. S., McGwin, G., Danila, M. I., Zhang, J., Bastian, H. M., Reveille, J. D., & Vilá, L. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24538 · Cited by 306
Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
Ramos-Casals, M., Soto, M., Cuadrado, M., & Khamashta, M. (2009) · Lupus · doi:10.1177/0961203309106174 · Cited by 304
Vigna-Perez, M., Hernández-Castro, B., Paredes-Saharopulos, O., Portales-Pérez, D., Baranda, L., Abud-Mendoza, C., & González-Amaro, R. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1954 · Cited by 303
Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy
Bao, H., Liu, Z.-H., Xie, H.-L., Hu, W.-X., Zhang, H.-T., & Li, L.-S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121272 · Cited by 301
Self-citationBaldwin, D. S., Gluck, M. C., Lowenstein, J., & Gallo, G. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90345-x · Cited by 300
Froissart, A., Buffet, M., Veyradier, A., Poullin, P., Provôt, F., Malot, S., Schwarzinger, M., Galicier, L., Vanhille, P., Vernant, J.-P., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822e9d66 · Cited by 291
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
The ACCESS Trial Group (2014) · Arthritis & Rheumatology · doi:10.1002/art.38790 · Cited by 288
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence
Brunetti, M., Shemilt, I., Pregno, S., Vale, L., Oxman, A. D., Lord, J., Sisk, J., Ruiz, F., Hill, S., Guyatt, G. H., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.04.012 · Cited by 286
Long-term follow-up of patients with lupus nephritis
Appel, G. B., Cohen, D. J., Pirani, C. L., Meltzer, J. I., & Estes, D. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90645-0 · Cited by 278
Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90151-m · Cited by 278
Lu, T. Y. ‐., Ng, K. P., Cambridge, G., Leandro, M. J., Edwards, J. C. W., Ehrenstein, M., & Isenberg, D. A. (2009) · Arthritis Care & Research · doi:10.1002/art.24341 · Cited by 275
Hydroxychloroquine retinopathy
Yusuf, I. H., Sharma, S., Luqmani, R., & Downes, S. M. (2017) · Eye · doi:10.1038/eye.2016.298 · Cited by 271
Scully, M., Cohen, H., Cavenagh, J., Benjamin, S., Starke, R., Killick, S., Mackie, I., & Machin, S. J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06448.x · Cited by 267
Mok, C. C., Kwok, R. C. L., & Yip, P. S. F. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38006 · Cited by 261
ONG, L. M., HOOI, L. S., LIM, T. O., GOH, B. L., AHMAD, G., GHAZALLI, R., TEO, S. M., WONG, H. S., TAN, S. Y., SHAARIAH, W., et al. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00444.x · Cited by 252
The natural history of the renal manifestations of systemic lupus erythematosus. 1964.
Pollak, V. E., Pirani, C. L., & Schwartz, F. D. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v871189 · Cited by 248
Díaz-Lagares, C., Croca, S., Sangle, S., Vital, E. M., Catapano, F., Martínez-Berriotxoa, A., García-Hernández, F., Callejas-Rubio, J.-L., Rascón, J., D'Cruz, D., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.009 · Cited by 246
Mok, C. C., Lau, C. S., & Wong, R. W. S. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199805)41:5<831::aid-art9>3.0.co;2-1 · Cited by 246
Kaiser, R., Cleveland, C. M., & Criswell, L. A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093013 · Cited by 244
Tamirou, F., Lauwerys, B. R., Dall'Era, M., Mackay, M., Rovin, B., Cervera, R., & Houssiau, F. A. (2015) · Lupus Science & Medicine · doi:10.1136/lupus-2015-000123 · Cited by 242
Self-citationGunnarsson, I., Sundelin, B., Jónsdóttir, T., Jacobson, S. H., Henriksson, E. W., & van Vollenhoven, R. F. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22505 · Cited by 241
Meher, S., Duley, L., Hunter, K., & Askie, L. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.016 · Cited by 239
Grootscholten, C., Erythematosus, F. T. D. W. P. O. S. L., Ligtenberg, G., Hagen, E. C., van den Wall Bake, A. W. L., de Glas-Vos, J. W., Bijl, M., Assmann, K. J., Bruijn, J. A., Weening, J. J., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001630 · Cited by 237
Russell, M. D., Dey, M., Flint, J., Davie, P., Allen, A., Crossley, A., Frishman, M., Gayed, M., Hodson, K., Khamashta, M., et al. (2023) · Rheumatology · doi:10.1093/rheumatology/keac551 · Cited by 236
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide
Ioannidis, J. P. A., Boki, K. A., Katsorida, M. E., Drosos, A. A., Skopouli, F. N., Boletis, J. N., & Moutsopoulos, H. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00832.x · Cited by 231
Duration of end-stage renal disease and kidney transplant outcome
Goldfarb-Rumyantzev, A., Hurdle, J. F., Scandling, J., Wang, Z., Baird, B., Barenbaum, L., & Cheung, A. K. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh541 · Cited by 228
Mok, C. C., Ying, K. Y., Yim, C. W., Siu, Y. P., Tong, K. H., To, C. H., & Ng, W. L. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206456 · Cited by 220
Hiraki, L. T., Feldman, C. H., Liu, J., Alarcón, G. S., Fischer, M. A., Winkelmayer, W. C., & Costenbader, K. H. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34472 · Cited by 219
Feldman, C. H., Hiraki, L. T., Winkelmayer, W. C., Marty, F. M., Franklin, J. M., Kim, S. C., & Costenbader, K. H. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39070 · Cited by 219
Tamirou, F., D'Cruz, D., Sangle, S., Remy, P., Vasconcelos, C., Fiehn, C., Ayala Guttierez, M. D. M., Gilboe, I.-M., Tektonidou, M., Blockmans, D., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206897 · Cited by 216
Rovin, B. H., Furie, R., Teng, Y. K. O., Contreras, G., Malvar, A., Yu, X., Ji, B., Green, Y., Gonzalez-Rivera, T., Bass, D., et al. (2022) · Kidney International · doi:10.1016/j.kint.2021.08.027 · Cited by 215
Self-citationAtisha‐Fregoso, Y., Malkiel, S., Harris, K. M., Byron, M., Ding, L., Kanaparthi, S., Barry, W. T., Gao, W., Ryker, K., Tosta, P., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41466 · Cited by 214
Taxonomy for systemic lupus erythematosus with onset before adulthood
Silva, C. A., Avcin, T., & Brunner, H. I. (2012) · Arthritis Care & Research · doi:10.1002/acr.21757 · Cited by 210
GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy
Blumenfeld, Z., & von Wolff, M. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn022 · Cited by 208
Radhakrishnan, J., Moutzouris, D.-A., Ginzler, E. M., Solomons, N., Siempos, I. I., & Appel, G. B. (2010) · Kidney International · doi:10.1038/ki.2009.412 · Cited by 207
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
Dima, A., Jurcut, C., Chasset, F., Felten, R., & Arnaud, L. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211073001 · Cited by 207
Petri, M. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-010-0141-y · Cited by 206
Chen, W., Tang, X., Liu, Q., Chen, W., Fu, P., Liu, F., Liao, Y., Yang, Z., Zhang, J., Chen, J., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.08.036 · Cited by 202
Self-citationMina, R., von Scheven, E., Ardoin, S. P., Eberhard, B. A., Punaro, M., Ilowite, N., Hsu, J., Klein‐gitelman, M., Moorthy, L. N., Muscal, E., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21558 · Cited by 198
Kasitanon, N., Fine, D. M., Haas, M., Magder, L. S., & Petri, M. (2006) · Lupus · doi:10.1191/0961203306lu2313oa · Cited by 197
Adherence to treatment in systemic lupus erythematosus patients
Costedoat-Chalumeau, N., Pouchot, J., Guettrot-Imbert, G., Le Guern, V., Leroux, G., Marra, D., Morel, N., & Piette, J.-C. (2013) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2013.07.001 · Cited by 190
Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis
Weidenbusch, M., Römmele, C., Schröttle, A., & Anders, H.-J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs285 · Cited by 190
Sisó, A., Ramos-Casals, M., Bové, A., Brito-Zerón, P., Soria, N., Muñoz, S., Testi, A., Plaza, J., Sentís, J., & Coca, A. (2008) · Lupus · doi:10.1177/0961203307086503 · Cited by 189
Rovin, B. H., Caster, D. J., Cattran, D. C., Gibson, K. L., Hogan, J. J., Moeller, M. J., Roccatello, D., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.008 · Cited by 185
Self-citationDe Rosa, M., Azzato, F., Toblli, J. E., De Rosa, G., Fuentes, F., Nagaraja, H. N., Nash, R., & Rovin, B. H. (2018) · Kidney International · doi:10.1016/j.kint.2018.05.021 · Cited by 182
Self-citationMoroni, G., Doria, A., Mosca, M., Alberighi, O. D. C., Ferraccioli, G., Todesco, S., Manno, C., Altieri, P., Ferrara, R., Greco, S., et al. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02271205 · Cited by 175
The long-term outcome of 93 patients with proliferative lupus nephritis
Moroni, G., Quaglini, S., Gallelli, B., Banfi, G., Messa, P., & Ponticelli, C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm245 · Cited by 173
Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome
Melander, C., Salle[Combining Acute Accent]e, M., Trolliet, P., Candon, S., Belenfant, X., Daugas, E., Re[Combining Acute Accent]my, P., Zarrouk, V., Pillebout, E. A. A., Jacquot, C., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04030808 · Cited by 169
Wofsy, D., Hillson, J., & Diamond, B. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34624 · Cited by 165
Kello, N., Khoury, L. E., Marder, G., Furie, R., Zapantis, E., & Horowitz, D. L. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.11.005 · Cited by 164
Mathian, A., Pha, M., Haroche, J., Cohen-Aubart, F., Hié, M., Pineton de Chambrun, M., Boutin, T. H. D., Miyara, M., Gorochov, G., Yssel, H., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216303 · Cited by 164
Dufrost, V., Risse, J., Reshetnyak, T., Satybaldyeva, M., Du, Y., Yan, X.-X., Salta, S., Gerotziafas, G., Jing, Z.-C., Elalamy, I., et al. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.04.009 · Cited by 161
Tseng, C., Buyon, J. P., Kim, M., Belmont, M. H., Mackay, M. C., Diamond, B., Marder, G. S., Rosenthal, P., HAINES, K. A., Ilie, V., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22198 · Cited by 158
Mortality in Systemic Lupus Erythematosus: an Updated Review
Nieves, C. E. F., & Izmirly, P. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0571-2 · Cited by 158
Leroux, M., Desveaux, C., Parcevaux, M., Julliac, B., Gouyon, J., Dallay, D., Pellegrin, J., Boukerrou, M., Blanco, P., & Lazaro, E. (2015) · Lupus · doi:10.1177/0961203315591027 · Cited by 156
Baseline characteristics of a multiethnic lupus cohort: PROFILE
Gs, A., McGwin, G., Petri, M., et al. (2002) · Lupus · doi:10.1191/9612332lu155oa · Cited by 153
Lakshminarayanan, S., Walsh, S. J., Mohanraj, M., & Rothfield, N. (2001) · PubMed · Cited by 152
Zeher, M., Doria, A., Lan, J.-L., Aroca, G., Jayne, D. R. W., Boletis, I. N., Hiepe, F., Prestele, H., Bernhardt, P., & Amoura, Z. (2011) · Lupus · doi:10.1177/0961203311418269 · Cited by 148
Role of early repeated renal biopsies in lupus nephritis
Zickert, A., Sundelin, B., Svenungsson, E., & Gunnarsson, I. (2014) · Lupus Science & Medicine · doi:10.1136/lupus-2014-000018 · Cited by 146
Clinical–Morphological Features and Outcomes of Lupus Podocytopathy
Hu, W., Chen, Y., Wang, S., Chen, H., Liu, Z., Zeng, C., Zhang, H., & Liu, Z. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06720615 · Cited by 144
Self-citationTreatment of catastrophic antiphospholipid syndrome
Kazzaz, N. M., McCune, W. J., & Knight, J. S. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000269 · Cited by 143
Malvar, A., Alberton, V. G., Lococo, B., Ferrari, M., Delgado, P., Nagaraja, H. N., & Rovin, B. H. (2019) · Kidney International · doi:10.1016/j.kint.2019.07.018 · Cited by 139
Self-citationPrevalence and predictors of fragility fractures in systemic lupus erythematosus
Yee, C., Crabtree, N. J., Skan, J., Amft, N., Bowman, S., Situnayake, D., & Gordon, C. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018127 · Cited by 130
Rovin, B. H., van Vollenhoven, R., Aranow, C. B., Wagner, C. L., Gordon, R. M., Zhuang, Y., Belkowski, S. M., & Hsu, B. L. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39722 · Cited by 129
Self-citationEffect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus.
Tam, L., Gladman, D. D., Hallett, D. C., Rahman, P., & Urowitz, M. B. (2000) · PubMed · Cited by 127
Immunosuppressive treatment for proliferative lupus nephritis
Tunnicliffe, D. J., Palmer, S. C., Henderson, L., Masson, P., Craig, J. C., Tong, A., Singh‐Grewal, D., Flanc, R. S., Roberts, M. A., Webster, A. C., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002922.pub4 · Cited by 127
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis
Szeto, C., Kwan, B. C., Lai, F. M., Tam, L., Li, E. K.-M., Chow, K.-M., Gang, W., & Li, P. K.-T. (2008) · Rheumatology · doi:10.1093/rheumatology/ken335 · Cited by 123
Low‐Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta‐Analysis
Xu, T., Zhou, F., Deng, C., Huang, G., Li, J. P., & Wang, X. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12541 · Cited by 121
Johnson, S. A., Stojanović, J., Ariceta, G., Bitzan, M. M., Beşbaş, N., Frieling, M. L., Karpman, D., Landau, D., Langman, C. B., Licht, C. P. B., et al. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2817-4 · Cited by 120
Human papillomavirus vaccine and systemic lupus erythematosus
Gatto, M., Agmon‐Levin, N., Soriano, A., Manna, R., Segal, R. M., Kivity, S., Doria, A., & Shoenfeld, Y. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2266-7 · Cited by 116
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Wijnsma, K. L., Duineveld, C., Wetzels, J. F. M., et al. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-4091-3 · Cited by 113
Malignancies in systemic lupus erythematosus
Goobie, G. C., Bernatsky, S., Ramsey‐Goldman, R., & Clarke, A. E. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000202 · Cited by 111
Ioannidis, J. P. A., Katsifis, G. E., Tzioufas, A. G., & Moutsopoulos, H. Μ. (2002) · PubMed · Cited by 111
Outcomes of rituximab therapy in refractory lupus: A meta-analysis
Alshaiki, F., Obaid, E. F., Almuallim, A. A., Taha, R., El-Haddad, H., & Almoallim, H. M. (2018) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2018.17096 · Cited by 111
Iaccarino, L., Bartoloni, E., Carli, L., Ceccarelli, F., Conti, F., Vita, S. D., Ferraccioli, G., Galeazzi, M., Gatto, M., Gerli, R., et al. (2015) · PubMed · Cited by 108
Ruiz‐Arruza, I., Lozano, J., Cabezas‐Rodríguez, I., Medina, J., Ugarte, A., Erdozain, J. G., & Ruiz‐Irastorza, G. (2017) · Arthritis Care & Research · doi:10.1002/acr.23322 · Cited by 107
Koike, R., Harigai, M., Atsumi, T., Amano, K., Kawai, S., Saito, K., Saito, T., Yamamura, M., Matsubara, T., & Miyasaka, N. (2009) · Modern Rheumatology · doi:10.3109/s10165-009-0197-6 · Cited by 104
Time to Recovery from Proteinuria in Patients with Lupus Nephritis Receiving Standard Treatment
Touma, Z., Urowitz, M. B., Ibañez, D., & Gladman, D. D. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130005 · Cited by 104
Galindo-Izquierdo, M., Almaraz, E. R., Pego‐Reigosa, J. M., López-Longo, F. J., Alén, J. C., Olivé, A., Fernández‐Nebro, A., Martínez-Taboada, V. M., Vela, P., Freire, M., et al. (2016) · Medicine · doi:10.1097/md.0000000000002891 · Cited by 104
Hodis, H. N., Quismorio, F. P., Wickham, E., & Blankenhorn, D. H. (1993) · PubMed · Cited by 103
Wang, H., Cui, T., Hou, F., Ni, Z., Chen, X., Lu, F., Xu, F., Yu, X., Zhang, F. S., Zhao, X., et al. (2008) · Lupus · doi:10.1177/0961203308089408 · Cited by 103
Prednisone in lupus nephritis: How much is enough?
Ruiz‐Irastorza, G., Danza, Ã., Perales, I., Villar, I., Garcia, M., Delgado, S., & Khamashta, M. A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.013 · Cited by 102
Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study
Jorge, A. M., Wallace, Z. S., Lu, N., Zhang, Y., & Choi, H. K. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1570 · Cited by 98
Dall’Era, M., Stone, D., Levesque, V., Cisternas, M. G., & Wofsy, D. (2010) · Arthritis Care & Research · doi:10.1002/acr.20397 · Cited by 97
Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma
Mok, C. C. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.14 · Cited by 95
A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children
Hansen, K. E., Kleker, B., Safdar, N., & Bartels, C. M. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.02.002 · Cited by 94
Steiman, A. J., Gladman, D. D., Ibañez, D., & Urowitz, M. B. (2011) · Arthritis Care & Research · doi:10.1002/acr.21568 · Cited by 93
Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment
Tektonidou, M. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01181 · Cited by 93
van Vollenhoven, R., Navarra, S., Levy, R. A., et al. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez279 · Cited by 91
Cortés-Hernández, J., Torres-Salido, M. T., Segarra-Medrano, A., Vilardell‐Tarrés, M., & Ordi‐Ros, J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq322 · Cited by 90
von Baeyer, H. (2002) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2002.00390.x · Cited by 88
Diagnosis of complement alternative pathway disorders
Angioi, A., Fervenza, F. C., Sethi, S. M., Zhang, Y., Smith, R. J., Murray, D. L., Praet, J. T. V., Pani, A., & Vriese, A. S. D. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.003 · Cited by 88
A review on SLE and malignancy
Choi, M. Y., Flood, K. S., Bernatsky, S., Ramsey‐Goldman, R., & Clarke, A. E. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.013 · Cited by 88
Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients with Connective Tissue Diseases
Vananuvat, P., Suwannalai, P., Sungkanuparph, S., et al. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.05.004 · Cited by 86
Mycophenolate therapy of SLE membranous nephropathy
Spetie, D. N., Tang, Y., Rovin, B. H., Nádasdy, T., Nadasdy, G. M., Pesavento, T. E., & Hebert, L. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66030.x · Cited by 85
Self-citationMeasuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring
Marengo, M. F., Waimann, C., de Achaval, S., Zhang, H., García-González, A., Richardson, M., Reveille, J. D., & Suarez-Almazor, M. E. (2012) · Lupus · doi:10.1177/0961203312447868 · Cited by 85
Yap, D. Y. H., Yu, X., CHEN, X., Lu, F., Chen, N., Li, X., TANG, C. S., & Chan, T. M. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01574.x · Cited by 82
Self-citationEffect of pregnancy on disease flares in patients with systemic lupus erythematosus
Petri, M., Howard, A. G., Franceschini, N., Eudy, A. M., Siega-Riz, A. M., Clowse, M. E. B., & Engel, S. M. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/2ha5-d032 · Cited by 81
Mok, C. C., Ho, L. Y., Ying, S. K. Y., Leung, M. C., To, C. H., & Ng, W. L. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217178 · Cited by 78
Bruce, I. N., Gladman, D., & Urowitz, M. B. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200012)13:6<406::aid-art11>3.0.co;2-2 · Cited by 75
Mok, C., To, C., Yu, K., & Ho, L. (2013) · Lupus · doi:10.1177/0961203313502864 · Cited by 74
Current treatment of atypical hemolytic uremic syndrome
Kaplan, B. S., Ruebner, R. L., Spinale, J. M., & Copelovitch, L. A. (2014) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2014.01001 · Cited by 74
Tse, K., Lam, M. F., Tang, S. C. W., Tang, S. C. W., & Chan, T. M. (2007) · Lupus · doi:10.1177/0961203306073167 · Cited by 67
Self-citationRecurrence of Secondary Glomerular Disease after Renal Transplantation
Ponticelli, C. E., Moroni, G. L., & Glassock, R. J. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09381010 · Cited by 67
What happens after complete withdrawal of therapy in patients with lupus nephritis.
Moroni, G. L., Longhi, S., Giglio, E., et al. (2013) · PubMed · Cited by 62
Ogawa, H., Kameda, H., Amano, K., & Takeuchi, T. (2009) · Lupus · doi:10.1177/0961203309350320 · Cited by 61
Kroese, S. J., de Hair, M. J. H., Limper, M., Lely, A. T., van Laar, J. M., Derksen, R. H. W. M., & Fritsch-Stork, R. D. E. (2017) · Journal of Immunology Research · doi:10.1155/2017/2810202 · Cited by 60
Tinti, M. G., Carnevale, V., Inglese, M., Molinaro, F., Bernal, M. A. B., Migliore, A., & Cata, A. D. (2019) · Clinical and Experimental Medicine · doi:10.1007/s10238-019-00565-8 · Cited by 59
Pokroy‐Shapira, E., Gelernter, I., & Molad, Y. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2527-0 · Cited by 56
Advances in the care of children with lupus nephritis
Wenderfer, S. E., Ruth, N. M., & Brunner, H. I. (2016) · Pediatric Research · doi:10.1038/pr.2016.247 · Cited by 56
Long-Term Outcomes of Children and Adolescents With Biopsy-Proven Childhood-Onset Lupus Nephritis
Chan, E. Y.-H., Yap, D. Y. H., Wong, W.-T., Wong, W. H. S., Wong, S.-W., Lin, K. Y., Hui, F. Y.-W., Yee-ming, J., Lam, S. S.-Y., Wong, J. K.-Y., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.10.014 · Cited by 55
Self-citationOral Cyclophosphamide for Lupus Glomerulonephritis
McKinley, A. M., Park, E., Spetie, D. N., Hackshaw, K. V., Nagaraja, S., Hebert, L. A., & Rovin, B. H. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02670409 · Cited by 54
Self-citationArriens, C., Teng, Y. K. O., Ginzler, E. M., Parikh, S. V., Askanase, A., Saxena, A., Gibson, K. L., Caster, D. J., Atsumi, T., Lisk, L., et al. (2022) · Arthritis Care & Research · doi:10.1002/acr.25007 · Cited by 54
HIV associated thrombotic microangiopathy
Ahmed, S. E., Siddiqui, R., Siddiqui, A. K., Zaidi, S. A., & Cervia, J. S. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.923.520 · Cited by 51
Rituximab alone as induction therapy for membranous lupus nephritis
Chavarot, N., Verhelst, D., Pardon, A., Caudwell, V., Mercadal, L., Sacchi, A., Leonardi, C. E., Guern, V. L., Karras, A., & Daugas, É. (2017) · Medicine · doi:10.1097/md.0000000000007429 · Cited by 48
Mejia-Vilet, J. M., Parikh, S. V., Song, H., Fadda, P., Shapiro, J. P., Ayoub, I. M., Yu, L., Zhang, J., Uribe‐Uribe, N., & Rovin, B. H. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy125 · Cited by 45
Self-citationVaccine-preventable infections in Systemic Lupus Erythematosus
Murdaca, G., Orsi, A., Spanò, F. M., Faccio, V., Puppo, F., Durando, P., Icardi, G., & Ansaldi, F. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1107685 · Cited by 43
A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination
Canney, M., Atiquzzaman, M., Cunningham, A., Zheng, Y., Lee, E., Hawken, S., Zhao, Y.-S., & Barbour, S. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022030258 · Cited by 43
Yapa, S. W. S., Roth, D. A., Gordon, D. N., et al. (2016) · Lupus · doi:10.1177/0961203316642309 · Cited by 41
Yong-wen, Z., Han, H., & Chu, L. (2020) · Clinics · doi:10.6061/clinics/2020/e1515 · Cited by 41
Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
Uchino, A., Tsukamoto, H., Nakashima, H., Yoshizawa, S., Furugo, I., Mitoma, H., Oryoji, K., Shimoda, T., Niiro, H., Tada, Y., et al. (2010) · PubMed · Cited by 40
Tanaka, H., Watanabe, S., Aizawa‐Yashiro, T., Oki, E., Kumagai, N., Tsuruga, K., & Ito, E. (2013) · Nephron Clinical Practice · doi:10.1159/000346149 · Cited by 40
Ruffatti, A., Tarzia, V., Fedrigo, M., Calligaro, A., Favarò, M., Macor, P., Tison, T., Cucchini, U., Cosmi, E., Tedesco, F., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.015 · Cited by 40
Fasano, S., Messiniti, V., Iudici, M., Coscia, M. A., & Ciccia, F. (2023) · Lupus Science & Medicine · doi:10.1136/lupus-2022-000841 · Cited by 40
Sedhain, A., Hada, R., Agrawal, R. K., Bhattarai, G. R., & Baral, A. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0973-7 · Cited by 39
Cited by
Systemic Lupus Erythematosus: A Review
Siegel, C. H., & Sammaritano, L. R. (2024) · JAMA · doi:10.1001/jama.2024.2315 · Cited by 535
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Furie, R. A., Rovin, B. H., Garg, J. P., Santiago, M. B., Aroca-Martínez, G., Zuta Santillán, A. E., Alvarez, D., Navarro Sandoval, C., Lila, A. M., Tumlin, J. A., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2410965 · Cited by 260
Self-citationEvaluating the performance of four anti-dsDNA antibody detection methods
Gao, X., Wu, L., Li, Y., Wang, L., Huang, Z., Zhang, J., Su, Z., & Yang, B. (2025) · Lupus · doi:10.1177/09612033251371116 · Cited by 1
Metadata
- Authors
- Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2024-01
- Volume
- 105
- Issue
- 1
- Pages
- S1-S69
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W4390533546
- Cited by
- 517
- References
- 226
- FWCI
- 141.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.